BR112012018840A2 - proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas - Google Patents

proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas

Info

Publication number
BR112012018840A2
BR112012018840A2 BR112012018840A BR112012018840A BR112012018840A2 BR 112012018840 A2 BR112012018840 A2 BR 112012018840A2 BR 112012018840 A BR112012018840 A BR 112012018840A BR 112012018840 A BR112012018840 A BR 112012018840A BR 112012018840 A2 BR112012018840 A2 BR 112012018840A2
Authority
BR
Brazil
Prior art keywords
proteins
vaccine
diagnostic
antibodies against
methods including
Prior art date
Application number
BR112012018840A
Other languages
English (en)
Inventor
Rosander Anna
Pringle Maerit
Original Assignee
Pringle Maerit
Rosander Anna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pringle Maerit, Rosander Anna filed Critical Pringle Maerit
Publication of BR112012018840A2 publication Critical patent/BR112012018840A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112012018840A 2010-01-28 2011-01-28 proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas BR112012018840A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29896010P 2010-01-28 2010-01-28
US36098610P 2010-07-02 2010-07-02
PCT/SE2011/050090 WO2011093783A1 (en) 2010-01-28 2011-01-28 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same

Publications (1)

Publication Number Publication Date
BR112012018840A2 true BR112012018840A2 (pt) 2017-06-20

Family

ID=44319584

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012018840A BR112012018840A2 (pt) 2010-01-28 2011-01-28 proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas

Country Status (10)

Country Link
US (1) US8703432B2 (pt)
EP (1) EP2528939B1 (pt)
JP (1) JP2013518563A (pt)
CN (1) CN102918053A (pt)
AU (1) AU2011209988A1 (pt)
BR (1) BR112012018840A2 (pt)
CA (1) CA2825282A1 (pt)
NZ (1) NZ601980A (pt)
RU (1) RU2012137304A (pt)
WO (1) WO2011093783A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010423B2 (en) 2013-03-15 2018-07-03 Avinash Kumar Anatomical humeral fixation system and method
EP3017814B1 (en) 2013-07-03 2018-01-31 Mitsubishi-Chemical Foods Corporation Method for preventing and/or treating digital dermatitis
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
EP3710047A1 (en) * 2017-11-17 2020-09-23 Hipra Scientific, S.L.U. Vaccine compositions for use against digital dermatitis in a mammal
KR102177180B1 (ko) * 2020-05-13 2020-11-10 순천대학교 산학협력단 신규 트레포네마 파지데니스 균주 및 이의 분리 방법
KR102177181B1 (ko) * 2020-05-14 2020-11-10 순천대학교 산학협력단 트레포네마 파지데니스 균주의 배양 조성물 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0534526A1 (en) * 1991-09-25 1993-03-31 Duphar International Research B.V Treponema hyodysenteriae vaccine
IL103530A0 (en) * 1991-10-25 1993-03-15 Duphar Int Res Treponema hyodysenteriae vaccine
US6096323A (en) * 1997-10-03 2000-08-01 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US6287575B1 (en) 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
US20130034560A1 (en) 2013-02-07
CA2825282A1 (en) 2011-08-04
RU2012137304A (ru) 2014-03-10
CN102918053A (zh) 2013-02-06
EP2528939A4 (en) 2013-07-03
WO2011093783A1 (en) 2011-08-04
EP2528939B1 (en) 2015-04-08
NZ601980A (en) 2014-08-29
US8703432B2 (en) 2014-04-22
AU2011209988A1 (en) 2012-09-13
EP2528939A1 (en) 2012-12-05
JP2013518563A (ja) 2013-05-23

Similar Documents

Publication Publication Date Title
IL261151A (en) Water-soluble membrane proteins, methods for their preparation and use
HK1200489A1 (en) Recombinant human naglu protein and uses thereof naglu
BR112014026990A2 (pt) anticorpo , ácido nucleico , vetores , célula hospedeira , composição farmacêutica , uso de um anticorpo e método para o tratamento de um paciente com necessidade de terapia.
IL279676A (en) Recombinant proteins and therapeutic uses
CO6650338A2 (es) Antígenos de tuberculosis modificados
PL3604339T3 (pl) Terapeutyczne przeciwciała przeciwko białku ror-1 i sposoby ich zastosowania
BR112013008410A2 (pt) sistema para uso em reparação tecidual
BR112014010658A2 (pt) antígenos e vacinas direcionadas contra enterovírus humano
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
CO7000778A2 (es) Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico
BR112013013756A2 (pt) conjunto de fixação pedicular multiaxial e método de uso
ZA201307641B (en) Human tissue factor antibody and uses thereof
BR112014010739A2 (pt) agentes terapêuticos e uso dos mesmos
BR112012016229A2 (pt) método para melhorar a sobrevida livre de progressão, método in vitro, kit, uso de um oligonucleotídeo ou polipetídeo e uso de bevacizumab
BR112012018840A2 (pt) proteínas recombinantes para uso em vacina, anticorpos contra as ditas proteínas e métodos de diagnósticos e terapêuticos incluindo as mesmas
BR112013022285A2 (pt) proteína de fusão de fgfr-fc e o seu uso
HK1198517A1 (en) Polyoma virus jc peptides and proteins in vaccination and diagnostic applications jc
BR112014005406A2 (pt) composição de vacina e respectivo uso
CL2015001689A1 (es) Parvovirus 5a porcino, métodos de uso y vacuna
BR112014000773A2 (pt) composições de nicotinamida e uso terapêutico das mesmas
BR112013012175A2 (pt) combinação, coadministração, uso e método
EP2610349A4 (en) FULL-PIPES, PREPARATION AND USE
BR112013013158A2 (pt) peptídeos de tomm34 e vacinas incluindo os mesmos
BR112013022164A2 (pt) peptídeo, vacina, e, anticorpo
BR112013002292A2 (pt) polipeptídeo du fusão, complexo de proteína, uso e kit

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]